Sectoral Asset Management Inc Travere Therapeutics, Inc. Transaction History

Sectoral Asset Management Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$5.44 - $9.5 $1.49 Million - $2.61 Million	274,623 New	274,623 $2.47 Million
Q2 2023 Aug 11, 2023	BUY	$15.3 - $22.61 $1.17 Million - $1.73 Million	76,700 Added 21.39%	435,313 $6.69 Million
Q1 2023 May 12, 2023	BUY	$17.82 - $22.89 $1.18 Million - $1.52 Million	66,293 Added 22.68%	358,613 $8.07 Million
Q4 2022 Feb 10, 2023	BUY	$18.47 - $26.14 $787,191 - $1.11 Million	42,620 Added 17.07%	292,320 $6.15 Million
Q3 2022 Nov 10, 2022	BUY	$22.91 - $28.63 $405,507 - $506,751	17,700 Added 7.63%	249,700 $6.15 Million
Q2 2022 Aug 15, 2022	BUY	$20.94 - $30.01 $4.86 Million - $6.96 Million	232,000 New	232,000 $5.62 Million

214

94.3M

1.2M

778K

Ticker TVTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 64,173,600
Market Cap $1.32B
Description
Travere Therapeutics, Inc., a biopharmaceutical company, focuses on the identification, development, commercialization, and delivering of therapies for the treatment of rare diseases. Its marketed products include Chenodal, a synthetic oral form of chenodeoxycholic acid for the treatment of radiolucent stones in gallbladders; Cholbam, a cholic a...

Get notified when there are updates to the investment portfolio of Sectoral Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Sectoral Asset Management Inc with notifications on news.